Multinationals are in line for a windfall from President Donald Trump's call to cut the tax rate on U.S. companies' stockpiled overseas earnings, but a select few would do better than others.
Apple and Pfizer may enjoy an extra earnings bump because of their previous accounting maneuvers, while companies including Microsoft, Merck & Co. and Exxon Mobil might have to log a one-time earnings hit, data recorded in their public filings suggest.
The difference, which could mean a bookkeeping boost of as much as $7.9 billion for Apple and $5.3 billion for Pfizer, can be found on both companies' balance sheets. Both have created multibillion-dollar "deferred tax liabilities" to reflect the U.S. taxes they expect to owe on their accumulated offshore income.
Complete your profile to continue reading and get FREE access to Treasury & Risk, part of your ALM digital membership.
Your access to unlimited Treasury & Risk content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical Treasury & Risk information including in-depth analysis of treasury and finance best practices, case studies with corporate innovators, informative newsletters, educational webcasts and videos, and resources from industry leaders.
- Exclusive discounts on ALM and Treasury & Risk events.
- Access to other award-winning ALM websites including PropertyCasualty360.com and Law.com.
*May exclude premium content
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
